Differentiation of NUT midline carcinoma by epigenomic reprogramming.
Cancer Res, 2011/4/01;71(7):2686-96.
Schwartz BE[1], Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH, Agoston ES, Reynoird N, Khochbin S, Ince TA, Christie A, Janeway KA, Vargas SO, Perez-Atayde AR, Aster JC, Sallan SE, Kung AL, Bradner JE, French CA
Affiliations
PMID: 21447744DOI: 10.1158/0008-5472.CAN-10-3513
Impact factor: 13.312
Abstract
NUT midline carcinoma (NMC) is a lethal pediatric tumor defined by the presence of BRD-NUT fusion proteins that arrest differentiation. Here we explore the mechanisms underlying the ability of BRD4-NUT to prevent squamous differentiation. In both gain-of and loss-of-expression assays, we find that expression of BRD4-NUT is associated with globally decreased histone acetylation and transcriptional repression. Bulk chromatin acetylation can be restored by treatment of NMC cells with histone deacetylase inhibitors (HDACi), engaging a program of squamous differentiation and arrested growth in vitro that closely mimics the effects of siRNA-mediated attenuation of BRD4-NUT expression. The potential therapeutic utility of HDACi differentiation therapy was established in three different NMC xenograft models, where it produced significant growth inhibition and a survival benefit. Based on these results and translational studies performed with patient-derived primary tumor cells, a child with NMC was treated with the FDA-approved HDAC inhibitor, vorinostat. An objective response was obtained after five weeks of therapy, as determined by positron emission tomography. These findings provide preclinical support for trials of HDACi in patients with NMC.
MeSH terms
Acetylation; Animals; Carcinoma, Squamous Cell; Cell Differentiation; Child; Female; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Mediastinal Neoplasms; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Proteins; Nuclear Proteins; Oncogene Proteins; Oncogene Proteins, Fusion; RNA, Small Interfering; Transfection; Transplantation, Heterologous; Vorinostat
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download